Pharmaceutical News

RSS

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Researchers at Chicago University have developed an innovative new anti-SARS-CoV-2 therapy called “Nanotraps” – a family of nano-enabled virus-trapping particles – which have shown positive results in vitro, in vivo, and in human ex vivo trials.

3 Feb 2021

Researchers survey repurposed drugs that inhibit SARS-CoV-2 replication in vitro

A new study by researchers at the University of Manchester, UK, reports on the compounds of interest that were identified as having potential for the treatment of COVID-19, from a library of almost 2,000 compounds from the APExBIO DiscoveryProbe library.

3 Feb 2021

Albumin: The Natural Choice for Diagnostic Tests

The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease

From Albumedix Ltd. 2 Feb 2021

India's Covaxin vaccine likely effective against UK SARS-CoV-2 variant: Study

A new preprint research paper, posted to the preprint server bioRxiv, presents data indicating that the Indian-made Covaxin vaccine candidate successfully neutralizes this variant, preventing infection when challenged by it.

1 Feb 2021

Use of antiviral and antiretroviral medication could have detrimental impact on crops

The increased global use of antiviral and antiretroviral medication could have a detrimental impact on crops and potentially heighten resistance to their effects, new research has suggested.

29 Jan 2021

Active cannabis dispensaries linked to reduced opioid-related mortality rates

Counties with a greater number of cannabis dispensary storefronts experience reduced numbers of opioid-related deaths relative to other locales, a recent University of California, Davis, study has found.

29 Jan 2021

Saliva-based and antibody tests expand testing capacity, track vaccine response

Mason scientists employ a rapid-result, saliva-based test that significantly expands testing capacity, and an antibody test that can track vaccine response.

28 Jan 2021

People who take opioid for chronic pain may find it hard to access new primary care clinics

People who take opioid medications for chronic pain may have a hard time finding a new primary care clinic that will take them on as a patient if they need one, according to a new "secret shopper" study of hundreds of clinics in states across the country.

28 Jan 2021

Study offers a new approach to control post-surgery pain

As surgeons balance the need to control their patients' post-surgery pain with the risk that a routine operation could become the gateway to long-term opioid use or addiction, a new study shows the power of an approach that takes a middle way.

28 Jan 2021

COVID-19 vaccines should be given to pregnant or breastfeeding people, argue experts

People who are pregnant, breastfeeding or trying to conceive should be offered the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine based on ethical grounds, argue authors of a commentary in CMAJ (Canadian Medical Association Journal).

28 Jan 2021

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Researchers have described the potential of the drug spironolactone, a potassium-sparing diuretic, and anti-androgen, in preventing or alleviating the severity of COVID-19 pneumonia, and in preventing pulmonary fibrosis.

27 Jan 2021

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.

27 Jan 2021

What do we know about the SARS-CoV-2 vaccines so far?

A new study surveys what we know so far about SARS-CoV-2 vaccine candidates from advanced clinical trials.

27 Jan 2021

New contraceptive gel contains spermicidal, anti-viral, libido-enhancing agents in one formulation

Researchers from North Carolina State University have created a trifunctional contraceptive gel that contains spermicidal, anti-viral and libido-enhancing agents in one formulation.

27 Jan 2021

Medicinal cannabis improves outcomes in Parkinson's patients

With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson's disease (PD).

27 Jan 2021

Flu vaccinations for hospital workers can substantially reduce influenza-related deaths

Pneumonia and the flu kill tens of thousands of Americans each year, racking up billions of dollars in medical costs and even more in lost productivity.

27 Jan 2021

Two-drug combination approach could be effective against bone cancer

An innovative approach to treating bone tumors - starving cancer cells of the energy they need to grow - could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, suggests a new study from Washington University School of Medicine in St. Louis.

27 Jan 2021

Pharmaceutical News

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Researchers survey repurposed drugs that inhibit SARS-CoV-2 replication in vitro

Albumin: The Natural Choice for Diagnostic Tests

India's Covaxin vaccine likely effective against UK SARS-CoV-2 variant: Study

Use of antiviral and antiretroviral medication could have detrimental impact on crops

Active cannabis dispensaries linked to reduced opioid-related mortality rates

Saliva-based and antibody tests expand testing capacity, track vaccine response

People who take opioid for chronic pain may find it hard to access new primary care clinics

Study offers a new approach to control post-surgery pain

COVID-19 vaccines should be given to pregnant or breastfeeding people, argue experts

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

What do we know about the SARS-CoV-2 vaccines so far?

New contraceptive gel contains spermicidal, anti-viral, libido-enhancing agents in one formulation

Medicinal cannabis improves outcomes in Parkinson's patients

Flu vaccinations for hospital workers can substantially reduce influenza-related deaths

Two-drug combination approach could be effective against bone cancer

Anti-emetic drug offers a promising approach to treat chronic myeloid leukemia

First-of-its-kind cardiovascular drug gets FDA approval based on study from Canadian VIGOUR Centre

Herd immunity to SARS-CoV-2 may not be achievable with current vaccines

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News